“…For the studies by Philipsen et al (2015) and Schönenberg et al (2017), each treatment group was compared with the equivalent control group, based on medication status and comparing NFB versus sham NFB, respectively. A total of 18 studies were excluded because they did not measure any of the outcomes considered in our review (Bachmann et al, 2018; Barth, Mayer, Strehl, Fallgatter, & Ehlis, 2017; Cowley, Holmström, Juurmaa, Kovarskis, & Krause, 2016; Hirvikoski, Waaler, Lindström, Bölte, & Jokinen, 2015; Janssen, de Vries, Hepark, & Speckens, 2017; Janssen et al, 2018; Kaiser, 1997; LaCount, Hartung, Shelton, Clapp, & Clapp, 2015; Schoenberg et al, 2014; Solanto, Marks, Mitchell, Wasserstein, & Kofman, 2008; Thompson & Thompson, 1998; Van der Oord et al, 2018; Virta, Hiltunen, Mattsson, & Kallio, 2015; Wang et al, 2016; Weiss et al, 2012; White & Shah, 2006; Zilverstand et al, 2017; Zwart & Kallemeyn, 2001); four because there were insufficient data in the article (Cole et al, 2016; Hirvikoski et al, 2011; Huang et al, 2019; Weiss & Hechtman, 2006); two for not including all participants who were at least 18 years old (Vidal-Estrada et al, 2015; Zylowska et al, 2008); two for including participants with severe substance abuse (Bihlar Muld, Jokinen, Bölte, & Hirvikoski, 2016) and personality disorders (Prada et al, 2015); and one because the treatment was self-applied (Moëll, Kollberg, Nasri, Lindefors, & Kaldo, 2015) or a formal diagnostic assessment for ADHD was not made (Wymbs & Molina, 2015).…”